Skip to content

PHIO PHARMACEUTICALS CORP.: filings

Every PHIO PHARMACEUTICALS CORP. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202628770001437749-26-026271
10-Q2026-05-07fiscal Q1 202628570001437749-26-015604
10-K2026-03-05fiscal FY 202532650001437749-26-007078
10-Q2025-11-13fiscal Q3 202528820001437749-25-034857
10-Q2025-08-14fiscal Q2 202533960001683168-25-006174
10-Q2025-05-15fiscal Q1 202534720001683168-25-003719
10-K2025-03-31fiscal FY 202440820001683168-25-002134
10-Q2024-11-14fiscal Q3 2024341030001683168-24-008120
10-Q2024-08-14fiscal Q2 2024341010001683168-24-005706
10-Q2024-05-09fiscal Q1 202432680001683168-24-003175
10-K2024-04-01fiscal FY 202339800001683168-24-002021
10-Q2023-11-09fiscal Q3 2023341040001683168-23-007809
10-Q2023-08-10fiscal Q2 2023341000001683168-23-005514
10-Q2023-05-11fiscal Q1 202334720001683168-23-003213
10-K2023-03-22fiscal FY 202240820001683168-23-001678
10-Q2022-11-10fiscal Q3 2022331020001683168-22-007528
10-Q2022-08-11fiscal Q2 202233980001683168-22-005565
10-Q2022-05-12fiscal Q1 202233700001683168-22-003516
10-K2022-03-22fiscal FY 202136720001683168-22-001833
10-Q2021-11-10fiscal Q3 202130880001683168-21-005420
10-Q2021-08-12fiscal Q2 202130840001683168-21-003476
10-Q2021-05-13fiscal Q1 202130640001683168-21-001971
10-K2021-03-25fiscal FY 202036740001683168-21-001062
10-Q2020-11-10fiscal Q3 202031920001683168-20-003809
10-Q2020-08-12fiscal Q2 202031880001683168-20-002649
10-Q2020-05-12fiscal Q1 202031660001683168-20-001519
10-K2020-03-26fiscal FY 201935730001683168-20-000969
10-Q2019-11-12fiscal Q3 201931900001683168-19-003526
10-Q2019-08-12fiscal Q2 201931880001683168-19-002547
10-Q2019-05-14fiscal Q1 201933710001683168-19-001519
10-K2019-03-27fiscal FY 201833680001683168-19-000795
10-Q2018-11-14fiscal Q3 201831840001683168-18-003390
10-Q2018-08-14fiscal Q2 201831840001683168-18-002282
10-Q2018-05-10fiscal Q1 201829540001193125-18-158327
10-K2018-03-26fiscal FY 201732640001193125-18-096053
10-Q/A2018-03-26fiscal Q3 201728660001193125-18-096031
10-Q/A2018-03-26fiscal Q2 201727660001193125-18-096008
10-Q/A2018-03-26fiscal Q1 201727490001193125-18-095994
10-Q2017-11-08fiscal Q3 201725600001193125-17-336446
10-Q2017-08-10fiscal Q2 201724600001193125-17-253552
10-Q2017-05-11fiscal Q1 201724450001193125-17-166563
10-K2017-03-30fiscal FY 201630620001193125-17-102730
10-Q2016-11-10fiscal Q3 201626700001193125-16-765096
10-Q2016-08-11fiscal Q2 201626700001193125-16-678578
10-Q2016-05-12fiscal Q1 201626510001193125-16-588016
10-K2016-03-30fiscal FY 201530620001193125-16-523721
10-Q2015-11-12fiscal Q3 201526710001193125-15-375630
10-Q2015-08-12fiscal Q2 201526710001193125-15-287233
10-Q2015-05-13fiscal Q1 201524480001193125-15-184836
10-K2015-03-30fiscal FY 201430610001193125-15-110334
10-Q2014-11-13fiscal Q3 201425670001193125-14-410208
10-Q2014-08-14fiscal Q2 201425670001193125-14-309149
10-Q2014-05-14fiscal Q1 201425490001193125-14-198000
10-K2014-03-28fiscal FY 201331770001193125-14-121519
10-Q2013-11-14fiscal Q3 201328740001193125-13-441091
10-Q2013-08-14fiscal Q2 201328890001193125-13-333766
10-Q2013-05-15fiscal Q1 201326720001193125-13-220846
10-K2013-03-29fiscal FY 201230750001193125-13-133515
10-Q2012-11-13fiscal Q3 201226870001193125-12-467372
10-Q2012-08-14fiscal Q2 201225850001193125-12-355540
10-Q2012-05-14fiscal Q1 201223390001193125-12-231684

Inspect the source

Entity
PHIO PHARMACEUTICALS CORP. / CIK 0001533040
Captured
2026-09-20T09:16:24.484Z
SEC response SHA-256
3d497c766bb52085888c84162d0eece19641e29f57094c03d5b5eed353d800d9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533040.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))